Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
Elevance Health Inc. logo

NASDAQ · ELV

Elevance Health Inc.

Healthcare · Medical - Healthcare Plans

$412.70

Up+$11.76 (+2.93%)

Updated Oct 10, 2026, 8:09 PM

SID Score

7.6/10

Composite research score

Smart Money

54/100

Neutral

Market cap
80.05B
P/E ratio
14.7
Dividend yield
1.66%
52-week range
$274.84 – $436.24
Volume
2.08M
Avg. volume
1.72M

Price performance · ELV

ELV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

ELV closed at $412.70 after 21 trading sessions, down 1.44% for the selected period.

Last close
$412.70
Period change
-1.44%
Period low
$381.67
Period high
$424.24
Daily close
View OHLC price history
ELV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$401.92$418.5599$400.94$412.702.08M
Oct 8, 2026$403.83$407.37$397.1236$400.94786.33K
Oct 7, 2026$401.00$410.54$399.98$404.31904.79K
Oct 6, 2026$396.68$400.97$394.4226$400.091.23M
Oct 5, 2026$387.67$395.9925$385.00$394.51712.11K
Oct 2, 2026$382.09$388.04$380.65$386.43892.68K
Oct 1, 2026$388.00$390.37$375.74$381.671.19M
Sep 30, 2026$391.91$396.14$383.04$388.821.3M
Sep 29, 2026$391.00$395.435$390.00$392.73934.76K
Sep 28, 2026$396.99$400.1675$392.44$394.591.34M
Sep 25, 2026$400.00$405.13$394.685$396.091.22M
Sep 24, 2026$397.00$400.97$394.31$398.251.17M
Sep 23, 2026$400.84$404.39$396.37$398.561.21M
Sep 22, 2026$412.07$412.75$401.38$402.431.12M
Sep 21, 2026$410.31$411.48$406.20$409.31933.96K
Sep 18, 2026$414.68$415.36$406.38$410.952.08M
Sep 17, 2026$414.59$418.78$411.71$414.261.19M
Sep 16, 2026$417.00$422.36$411.656$412.561.12M
Sep 15, 2026$423.00$423.56$415.81$417.541.48M
Sep 14, 2026$422.54$427.17$420.28$424.241.12M
Sep 11, 2026$420.00$426.39$413.09$418.721.36M

Latest ELV news

The latest Smart Investors Daily articles mentioning ELV.

Stock researchCompany · Overview

ELV research

Overview

Company profile and research snapshot.

Company profile

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$389.63
Implied upside
—
Analysts
20
ELV recent ratings
DateFirmRatingTarget
Oct 7, 2026BarclaysOverweight—
Jul 17, 2026Leerink PartnersMarket Perform—
Jul 16, 2026Wells FargoOverweight—
Jul 16, 2026RBC CapitalSector Perform—
Jul 16, 2026GuggenheimBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 27, 2026

Evaluating Elevance Health (ELV) After Prolonged Share Price Weakness And 17.3% Undervaluation Estimate

With no single headline event driving attention, Elevance Health (ELV) has drawn investor interest after a mixed share price record, including a 16.18% decline over the past year and a 27.89% decline over three years. See our latest analysis for Elevance Health. Recent trading has been soft, with a 7 day share price return of 7.22% and a year to date share price return decline of 8.81%, while the 1 year total shareholder return decline of 16.18% and 3 year total shareholder return decline of...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By